Indication
Partial Seizure
2 clinical trials
3 products
Product
BrivaracetamClinical trial
An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.Status: Active (not recruiting), Estimated PCD: 2023-03-30
Product
CenobamateClinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label ExtensionStatus: Active (not recruiting), Estimated PCD: 2024-02-01
Product
Placebo